Although several lines of evidence support the role of Ki67 as a prognostic and predictive marker in BC,10, 11, 12, 13, 14 even as a marker for selection of candidates for adjuvant chemotherapy,47 both its widespread implementation and recommendation by guidelines have been plagued by well-described analytical weaknesses and interobserver variability in scoring.32 Here, MKI67 is linked to breast cancer.